Non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC) require different treatment conversations. Histology, Stage 3 or Stage 4 status, molecular findings, PD-L1 status and previous response can substantially affect the available standard options.
CARE ACROSS THE CANCER JOURNEY
Sunridge treats patients at every stage of cancer—including recurrent cancer.
Many patients contact Sunridge after previous treatment because their cancer has returned or progressed. Our physicians take another careful look at the current disease, prior treatment and response, pathology, biomarkers, immune function and overall health before discussing treatment options that may be appropriate. When clinically relevant, this evaluation may include specialized immune-function laboratory testing and testing for environmental or chemical exposures. Sunridge also offers physician-directed cancer-risk assessment, prevention planning and genetic testing.
Recently diagnosedClarify the diagnosis, stage and decisions ahead.
During treatmentReview coordinated supportive-care options and changing needs.
Recurrent, advanced or stage 4Reassess prior treatment, response, current disease and available next steps.
Risk and preventionDiscuss family history, inherited risk and clinically appropriate genetic testing.
20,000+patients served across Sunridge history
Thousandsof treatments administered each year
Onsitephysicians, nurses and dedicated treatment rooms
Worldwidepatients travel to Scottsdale for care
★★★★★
“The entire office staff is 5 stars incredible, kind, hospitable, comfortable and more!”
★★★★★
“From the moment we walked in, the entire staff—from the front desk to the nurses—was incredibly friendly, supportive, and professional.”
★★★★★
“From the moment we walked in, we were treated like VIP clients. Dr. Franco is very knowledgeable.”
These are individual patient experiences. Results vary, and testimonials do not predict or guarantee outcomes for another person.
Explore patient experiences →A MORE USEFUL FIRST REVIEW
The details that help define a lung cancer case
Cancer type and stage
Confirmed histology, location and extent of disease establish the starting point.
Biomarker testing
Actionable alterations and immune markers may be relevant to standard targeted or immune therapies.
Breathing and overall health
Pulmonary function, symptoms, medications and treatment tolerance remain central to planning.
WHAT TO EXPECT
A broader review without losing clinical focus
01Review the evidence
Understand what the pathology, imaging and molecular information currently show.
Review the sequence
Consider surgery, radiation and systemic-care questions in the appropriate clinical order.
Coordinate thoughtfully
Discuss whether physician-directed integrative support can fit alongside an existing oncology plan.
LUNG CANCER QUESTIONS
Lung cancer treatment and second-opinion questions
The appropriate options depend on the exact diagnosis, stage, pathology, molecular findings, previous treatment, response, lung function and overall health. A physician must review the individual record before recommending care.
What treatment options are considered for non-small-cell lung cancer (NSCLC)?
Depending on stage and tumor characteristics, standard options may include surgery, radiation therapy, chemotherapy, immunotherapy, targeted therapy or a combination. Biomarker and PD-L1 results can be especially important when reviewing systemic-treatment choices.
How is small-cell lung cancer (SCLC) reviewed?
SCLC is often discussed according to whether it is limited-stage or extensive-stage disease, along with previous treatment, response, symptoms and overall health. Treatment sequencing can differ substantially from NSCLC and requires an individualized physician review.
What records are useful for a lung cancer second opinion?
Helpful records commonly include the pathology report, imaging reports and images, staging information, molecular or biomarker testing, PD-L1 results when available, prior treatment summaries, medication lists and recent laboratory results.
Is lung cancer curable, and what affects prognosis?
The answer varies by cancer type, stage, molecular features, overall health and response to treatment. Some early-stage cancers may be treated with curative intent, while advanced disease may require ongoing treatment and monitoring. A records-based consultation can provide context for an individual situation without making guarantees.
Which standard treatments may be discussed?
Depending on the diagnosis, standard options can include surgery, radiation, chemotherapy, immunotherapy and targeted therapy. The right sequence and combination depend on the individual case and should be reviewed with the treating oncology team.
YOUR NEXT STEP CAN BE A CONVERSATION
Ready to discuss your cancer diagnosis?
Speak with our Patient Care Team at no charge. Tell us what you are facing and we will explain what information may be helpful before a physician consultation.
Read the detailed lung cancer care guide →